Lantern Pharma (LTRN)'s 30-day implied volatility (IV30) was 118.3% at the close on October 22, 2026, down from 129.5% the day before, against a 52-week range of 68.7% to 161.0%. Its 20-day historical volatility was 146.2%.
Data as of October 22, 2026.